Articles by Jyotsna Ramani
I have done by Post Graduation in Tourism from College of Vocational Studies apart from a full time MBA degree in Finance.I have worked with several reputed companies including IBM, MakeMyTrip and Habitat World. I love to read, write and travel. Currently, I am a SAHM ,earning a living off the stock market and making a killing with forex trades. I am sharing my knowledge so as to help others learn and expand their horizon.
ARCA Biopharma, Inc (NASDAQ:ABIO) has announced that they have submitted a study protocol for review under Food and Drug Administration’s Special Protocol Assessment (SPA) process for the design of a clinical trial to assess the …
Xcorporeal Inc (OTC:XCRP) has announced that they have signed an asset purchase agreement with National Quality Care Inc (NQCI) and Fresenius USA, Inc to sell substantially all of the assets of the Seller to the …
Arrowhead Research Corporation (NASDAQ:ARWR) has announced that they have raised approximately $3.2 million in gross proceeds from a private placement of approximately 6.0 million units.
ProtoKinetix Inc (OTC:PKTX) has announced that they have recently been approached by a European biopharma investment group with a series of proposals for development of commercial partnerships in the areas like pharmaceuticals and cosmetics.
Advaxis Inc (OTC:ADXS) has announced that they will be collaborating their Phase 2 trial with the Gynecologic Oncology Group which is a collaborative research of National Cancer Institute.
GTx, Inc (NASDAQ:GTXI) has announced that they will be reducing their workforce due to delay in the potential commercialization of toremifene 80 mg that reduces fractures in men with prostrate cancer on androgen deprivation therapy …
BioMimetic Therapeutics Inc (NASDAQ:BMTI) has announced that they have shipped their first order of Augment Bone Graft to their Canadian distributor, Joint Solutions Alliance Corporation.
Fero Industries, Inc (OTC:FROI) has announced their growth strategy publicly where they have disclose about Fero Industries first acquisition target which is Pyro Pharmaceuticals.
Medifocus, Inc (OTC:MDFZE) has announced that they have begun trading their common stock on the over the counter (OTC) pink sheets market from Dec. 7, 2009.
Neoprobe Corporation (OTC:NEOP) has announced that they have completed their Phase 3 clinical trial of Lmyphoseek (NEO3-35) with positive results and that they have submitted the data to US Food and Drug Administration to discuss …
